PEGylation Technology
PEGylation has been a highly effective commercial strategy for the development of blockbuster therapeutics, such as Roche's PEGASYS? (interferon) and Amgen's Neulasta? (G-CSF).
PEG (polyethylene glycol), a versatile technology, is a water soluble, amphiphilic, non-toxic, non-immunogenic compound that is safely cleared from the body. Its primary use to date in currently approved drugs is to favorably alter the pharmacokinetic properties of biologics. Early approaches to PEGylation were tremendously successful in creating blockbuster biologics but these did not fully leverage the flexibility and potential of the technology.
The limitations of older PEGylation approaches used with biologics are:
- Sub-optimal bioavailability and bioactivity
- Product is altered by PEG remaining attached to parent drug
- Limited ability to fine-tune properties of drug
- Did not allow for oral administration
- Not applicable to small molecules, antibody fragments, and peptides
Related products:
Product |
Mw(PEG raw material) |
replacement rate |
PD |
mPEG-OH-10K |
10000±1000 |
|
≤1.06 |
mPEG-OH-20K |
20000±2000 |
|
≤1.06 |
mPEG-OH-30K |
30000±3000 |
|
≤1.08 |
mPEG-NH2-2K |
2000±200 |
≥95% |
≤1.05 |
mPEG-NH2-5K |
5000±500 |
≥95% |
≤1.05 |
mPEG-NH2-10K |
10000±1000 |
≥95% |
≤1.06 |
mPEG-NH2-20K |
20000±2000 |
≥90% |
≤1.08 |
mPEG-NH2-30K |
30000±3000 |
≥90% |
≤1.08 |
mPEG-SC-2K |
2000±200 |
≥95% |
≤1.05 |
mPEG-SC-5K |
5000±500 |
≥95% |
≤1.05 |
mPEG-SC-10K |
10000±1000 |
≥95% |
≤1.06 |
mPEG-SC-20K |
20000±2000 |
≥90% |
≤1.08 |
mPEG-SC-30K |
30000±3000 |
≥90% |
≤1.08 |
mPEG-MAL-20K |
20000±2000 |
≥90% |
≤1.08 |
mPEG-MAL-30K |
30000±3000 |
≥90% |
≤1.08 |
mPEG--COOH-2K |
2000±200 |
≥95% |
≤1.05 |
mPEG-COOH-5K |
5000±500 |
≥95% |
≤1.05 |
mPEG-COOH-10K |
10000±1000 |
≥95% |
≤1.06 |
mPEG-COOH-20K |
20000±2000 |
≥90% |
≤1.08 |
mPEG-COOH-30K |
30000±3000 |
≥90% |
≤1.08 |
mPEG-SPA-2K |
2000±200 |
≥95% |
≤1.05 |
mPEG-SPA-5K |
5000±500 |
≥95% |
≤1.05 |
mPEG-PA-2K |
~2000 |
≥95% |
≤1.05 |
mPEG-PA-3.4K |
~3400 |
≥95% |
≤1.05 |
mPEG-NHS-10K |
10000±1000 |
≥90% |
≤1.06 |
mPEG-NHS-20K |
20000±2000 |
≥90% |
≤1.08 |
mPEG-NHS-30K |
30000±3000 |
≥90% |
≤1.08 |
mPEG-AC-2K |
2000±200 |
≥95% |
≤1.05 |
mPEG-AC-5K |
5000±500 |
≥95% |
≤1.05 |
mPEG-AC-10K |
10000±1000 |
≥90% |
≤1.06 |
mPEG-AC-20K |
20000±2000 |
≥90% |
≤1.08 |
mPEG-AC-30K |
30000±3000 |
≥90% |
≤1.08 |
mPEG-Ms-2K |
2000±200 |
≥95% |
≤1.05 |
mPEG- Ms -5K |
5000±500 |
≥95% |
≤1.05 |
mPEG- Ms -10K |
10000±1000 |
≥90% |
≤1.06 |
mPEG- Ms -20K |
20000±2000 |
≥90% |
≤1.08 |
mPEG- Ms -30K |
30000±3000 |
≥90% |
≤1.08 |
Bi-NH2-2K |
2000±200 |
≥95% |
≤1.05 |
Bi-NH2-3.4K |
3400±340 |
≥95% |
≤1.05 |
Bi-NH2-4K |
4000±400 |
≥95% |
≤1.05 |
Bi-NH2-6K |
5000±500 |
≥95% |
≤1.05 |
Bi-NH2-10K |
10000±1000 |
≥90% |
≤1.06 |
Bi-NH2-20K |
20000±2000 |
≥90% |
≤1.08 |
Bi-COOH-2K |
2000±200 |
≥95% |
≤1.05 |
Bi-COOH-3.4K |
3400±340 |
≥95% |
≤1.05 |
Bi-COOH-4K |
4000±400 |
≥95% |
≤1.05 |
Bi-COOH-6K |
5000±500 |
≥95% |
≤1.05 |
Bi-COOH-10K |
10000±1000 |
≥95% |
≤1.06 |
Bi-COOH-20K |
20000±2000 |
≥90% |
≤1.08 |
4-arm-PEG-5K |
5000±500 |
|
≤1.05 |
4-arm-PEG-10K |
10000±1000 |
|
≤1.06 |
4-arm-PEG-20K |
20000±2000 |
|
≤1.07 |
4-arm-NH2-5K |
5000±500 |
|
≤1.05 |
4-arm-NH2-10K |
10000±1000 |
|
≤1.06 |
4-arm-NH2-20K |
20000±2000 |
|
≤1.07 |
HO-PEG-NH2-2K |
2000±200 |
≥95% |
≤1.05 |
HO-PEG-NH2-3.4K |
3400±340 |
≥95% |
≤1.05 |
HO-PEG-NH2-0.6K |
|
|
|
HO-PEG-COOH-2K |
2000±200 |
≥95% |
≤1.05 |
HO-PEG-COOH-3.4K |
3400±340 |
≥95% |
≤1.05 |
NH2-PEG-COOH-2K |
2000±200 |
≥95% |
≤1.05 |
NH2-PEG-MAL-2K |
2000±200 |
≥95% |
≤1.05 |
Acryl-PEG-NHS-2K |
2000±200 |
≥95% |
≤1.05 |
![]() |
![]() |
![]() |
官網(wǎng):www.baichuan365.com | 微信服務(wù)號(hào):iseebio | 微博:seebiobiotech |
![]() |
![]() |
![]() |
商城:mall.seebio.cn | 微信訂閱號(hào):seebiotech | 泉養(yǎng)堂:www.canmedo.com |
相關(guān)資訊
- Continuous Centrifuge 管式連續(xù)流離心機(jī)
- JRSI:利用CRISPR-噬菌體共進(jìn)化解釋混亂的實(shí)驗(yàn)結(jié)果
- 免疫組織化學(xué)試劑盒
- 熱烈祝賀西寶生物成為愛爾蘭Aalto代理
- Nature:挑戰(zhàn)常規(guī)!新研究揭示可讓皮層中的祖細(xì)胞返老還童
- 《科學(xué)》預(yù)測(cè)2015年重要突破
- Nature:重磅!利用CRISPR–Cas系統(tǒng)將數(shù)字視頻存儲(chǔ)到一群細(xì)菌的基因組中
- BioPorto2011產(chǎn)品目錄
- Science解讀!揭秘輪狀病毒誘發(fā)嚴(yán)重胃腸道疾病的分子機(jī)制!
- 納米級(jí)特氟龍/PTFE膜用聚四氟乙烯樹脂
新進(jìn)產(chǎn)品
同類文章排行
- 膽堿酯酶檢測(cè)原料一覽
- 猴痘病毒檢測(cè)原料(涵蓋診斷酶、抗原、抗體),西寶生物助力猴痘檢測(cè)
- 西寶生物CHO細(xì)胞、HEK293細(xì)胞、 Vero細(xì)胞培養(yǎng)基產(chǎn)品
- 人和動(dòng)物免疫球蛋白IgG全新上市
- 如何選擇合適的表面活性劑?
- 尿液分析試紙檢測(cè)原理及產(chǎn)品推薦
- 總膽紅素/直接膽紅素檢測(cè)一站式解決方案
- 分子診斷用酶原料一站式服務(wù)盡在西寶生物
- 體外診斷中交聯(lián)劑的用途與選擇
- 優(yōu)異的化妝品級(jí)水溶性β-1,3-葡聚糖
資訊文章
您的瀏覽歷史
